Favipiravir shows significant improvement in time to clinical cure for mild to moderate COVID-19 Read more
Remdesivir and favipiravir price regulation required to safeguard patients’ interest in India: GlobalData Read more
DCGI queries pharma company on its claim of FabiFlu use for COVID-19 patients with comorbidities Read more